COVANCE TO PRESENT AT THE UBS GLOBAL LIFE SCIENCES CONFERENCE

Princeton, New Jersey — Covance Inc. (NYSE: CVD) announced that it will present at the UBS Global Life Sciences Conference on September 27 at 3:00 pm EDT. In order to register and download any necessary software, please log on 15 minutes early.

Covance, with headquarters in Princeton, New Jersey, is one of the world¹s largest and most comprehensive drug development services companies with annual revenues greater than $1 billion, global operations in 17 countries, and approximately 7,000 employees worldwide. Information on Covance's products and services, recent press releases, and SEC filings can be obtained through the Covance website.

Contact:
Covance@digitalbrandexpressions.com